The Canadian Organization of Medical Physicists (COMP), in close partnership with the Canadian Partnership for Quality Radiotherapy (CPQR) has developed a series of Technical Quality Control (TQC) guidelines for radiation treatment equipment.
This document contains detailed performance objectives and safety criteria for Computed Tomography simulators. The development of the individual TQC guidelines is spearheaded by expert reviewers and involves broad stakeholder input from the medical physics and radiation oncology community. 1 All information contained in this document is intended to be used at the discretion of each individual center to help guide quality and safety program improvement. There are no legal standards supporting this document; specific federal or provincial regulations and license conditions take precedence over the content of this document.
| SYSTEM DESCRIPTION
The purpose of radiation planning simulation is to simulate as accurately as possible the patient's position, shape, and anatomy relative to the radiation therapy machine and isocenter. [2] [3] [4] Modern treatment machines are able to achieve mechanical accuracies in the range of AE1 mm and AE1°and, so too, shall the simulators used to plan these radiation treatments. The process of radiation treatment planning frequently involves the following steps: For the purpose of this document, steps 1, 2, and 3 define the process of CT simulation. Steps 1, 2, 3, and sometimes 4, occur with the patient present in the CT scanner room.
CT simulators consist of a state-of-the-art spiral (or helical) CT scanner, 5, 6 the associated acquisition/processing computer system, a patient laser marking system, and radiation treatment accessories.
CT images provide the anatomical, geometrical, and relative electron density information necessary for the precision radiation planning.
The CT computer is networked to a 3D virtual simulation workstation or full radiation treatment planning (RTP) system. These workstations provide software tools for the localization of the targets, coregistration of the CT images with other imaging modalities, graphical planning of the radiation beams, and the production of digitally reconstructed radiographs (DRRs) in a beam's eye view (BEV). The difference between 3D virtual simulation workstations and full RTP systems is the dose calculation and dose evaluation capabilities that are integral with the latter. The process of CT simulation has been described in detail by various authors. 10 and other resources providing further information on tests and CT characteristics. 3, 11, 12 Included in the scope of this document is four-dimensional computed tomography (4D-CT), which has been developed to character- Tables 1-4 present the daily, monthly, quarterly, and annual recommended tests, which are described below.
Notes on Daily Tests
D1 Alignment of lasers should minimally match the tolerance set for those in the treatment delivery rooms. The daily laser test is meant to ensure that the gantry lasers accurately identify the scan plane within the gantry opening. A simple phantom can be used to perform this test, as detailed in Mutic et al., 2003. 8 The wall laser position with respect to the imaging plane shall be verified as this distance is used for patient localization marking. Finally, the accuracy of wall and ceiling laser motion shall be checked daily using displacement values within the full range of laser motion. This latter test can be simply performed with a ruler.
D2
The mean CT number of water shall be checked using a typical CT simulation protocol and a cylindrical water phantom, using a large region of interest (ROI). 10 The protocol used for the test should alternate to cover all kVp used clinically if applicable. The action level defined for this test is the one recommended in Safety Code 35.
10
D3 The standard deviation of CT numbers of water shall be checked using a typical CT simulation protocol and a cylindrical water phantom, using a large ROI located at the center of the phantom. 10 The Notes on Quarterly tests Q1-4 CT image performance is highly dependent on the scan technique used. These tests should be conducted for typical oncology protocols, for all kVp used clinically. Action levels should be developed locally depending on the equipment available. Routine monitoring of these parameters should be based on performance at installation.
Q5
The ability of the respiratory monitoring system to accurately monitor the motion of an external surrogate is crucial for ensuring 4D-CT reconstruction integrity. For systems that use external marker blocks, the amplitude and periodicity of the external block should be performed with a programmable respiratory motion phantom (e.g., Quasar TM Respiratory
Motion Phantom, Modus Medical Devices, London, Canada). The phantom must contain a target of known geometry and with enough contrast to surrounding static portions of the phantom to be visualized on CT and must be compatible with the external surrogate used for clinical 4D-CT reconstruction. The monitoring software must be able to calculate accurately the amplitude of the external surrogate. At minimum, a single amplitude within typical clinical range (e.g., 1-2 cm peak-to-peak) is required, but varying amplitudes allow for a more comprehensive test. The same applies to varying periodicity of the phantom. Motion in the superior/inferior direction only is permitted. However, motion of the target in all 3 dimensions allows for a more comprehensive test as long as the 3D trajectory is known. The action level defined for this test must be within 2 mm and the known respiratory motion period within 0.1 s. For systems that use a bellows device or Anzai belt, ensuring functionality (e.g., checking for leaks in the bellows device) and reproducibility of the signal is required.
Q6
For each 4D-CT protocol used clinically, ensure that the console software reconstructs the data into the appropriate number of respiratory phases, each containing the same number of axial slices.
Q7
The amplitude of the internal target must be measured using the 4D-CT datasets. This can be accomplished by using appropriate imaging grid tools or by calculating the centroid motion of the internal target(s). The action level defined for this test must be within 2 mm of known amplitude.
Q8
The geometry, including the target diameter, as well as the location of the target at all respiratory phases should be reproducible. The diameter can be calculated either using the grid tools or by a centrally located line profile in the direction of target motion and perpendicular to the target motion, where the full-width-half-maximum value (FWHM) can be extracted. The location of the target at all phases can be calculated using on console grid tools. The action level defined for this test must be within 2 mm of those established at acceptance. The tolerance can be increased for amplitudes greater than 2 cm.
Q9
The mean CT number of the moving target(s) shall be checked using standard CT simulation protocols at each phase of the respiratory cycle. This should be performed for each 4D-CT protocol used clinically. Also, the mean CT number must not vary significantly across all respiratory phases. The standard deviation of CT numbers of the moving target shall be checked at all phases of the respiratory cycle using either a 2D-ROI representing at least 40% of the target diameter located near the target center or a 3D-ROI representing at least 40% of the target volume. The recommended action level defined for these tests are (AE10 HU) from the mean CT number measured at acceptance and (AE10%) of the standard deviation measured at baseline. The tolerance can be increased for amplitudes greater than 2 cm.
Q10
Any post processed image creation used for radiation treatment planning using 4D-CT images should be tested. This includes the creation of time averaged CT images, maximum intensity projection (MIP) images, and minimum intensity projection images (MinIP). This can be verified by using the on console grid tool and line profile to measure the diameter of the target and the expected CT number variation in the direction of motion. The action level defined for this test must be within 2 mm of those established at acceptance. The tolerance can be increased for amplitudes greater than 2 cm.
Q11
Successful export of the 4D-CT dataset into the treatment planning system must be demonstrated. 
A3
The gantry tilt shall be 0°for radiation therapy applications. The digital gantry angle readout shall be verified using a level for gantry 0°. Additionally, it shall be checked that the gantry accurately returns to its nominal position after tilting. This test shall ideally be performed during a quarterly preventative maintenance inspection with the CT cosmetic cover removed. It is the responsibility of the CT personnel to make sure than the gantry tilt is 0°before any CT simulation exam. Ideally, a CT dedicated exclusively to radiation oncology simulation should not allow scans when the gantry is tilted.
A4-6 4D-CT image performance is highly dependent on the protocol used. These tests should be conducted for each kVp and mAs used clinically, as well as for each 4D-CT reconstruction technique used clinically (time-based, phase-based, or amplitude-based). Ideally, this can be accomplished by using CT-QA phantoms, such as the CATPHAN â (The Phantom Laboratory, Salem, USA), that can be motion driven (e.g., CATPHAN Shaker, Modus Medical Devices, London, Canada). However, an acceptable alternative is to use a simple motion phantom to drive 4D-CT reconstruction, but keeping the CT-QA phantom static. An alternative phantom could include a customized insert to an already existing programmable respiratory motion phantom that can capture the same imaging metrics as the CATPHAN. Action levels should be developed locally. Annual monitoring of these parameters should be based on performance at installation.
A7
To verify the complete CT simulation process, it is recommended that a simulated planning test be part of a quality assurance program. A phantom with various markers can be scanned with a CT simulation protocol; the images transferred and virtually simulated, and marked with the lasers according to the laser/couch output data.
A8 Documentation relating to the daily quality control checks, preventive maintenance, service calls, and subsequent checks shall be complete, legible, and the operator identified.
A9
To ensure redundancy and adequate monitoring, a second qualified medical physicist shall independently verify the implementation, analysis, and interpretation of the quality control tests at least annually. This verification shall be documented.
